Showing 1,441 - 1,460 results of 102,783 for search '(( 2 wt decrease ) OR ( 5 ((((nn decrease) OR (a decrease))) OR (teer decrease)) ))', query time: 1.28s Refine Results
  1. 1441
  2. 1442
  3. 1443
  4. 1444
  5. 1445

    VDR-dependent transcriptional activity of vitamin D derivatives in ATDC5 cells and analysis of the effect of binding to DBP. by Yoshihisa Hirota (616015)

    Published 2018
    “…<p>(A) Concentration dependence of the effects of vitamin D derivatives on VDR-dependent transcriptional activity of <i>CYP24A1</i> in ATDC5 cells. …”
  6. 1446

    Upcycling of Postconsumer Recyclate Polypropylene into Low Warping and High Toughness 3D Printable Filaments by Animesh Gopal (18521180)

    Published 2025
    “…Incorporation of poly­(butylene adipate-<i>co</i>-terephthalate) (PBAT) along with maleic anhydride grafted polypropylene (MAPP) in specific proportions led to a significant enhancement in mechanical properties, miscibility, crystallization behavior, and 3D printability. rPP/PBAT blends with 20 wt % PBAT and 10 wt % MAPP exhibited a 62-fold enhancement in elongation at break over rPP (from 1.88 to 118.29%) and a 72-fold increase in toughness (from 2 to 143.60 kJ/m<sup>3</sup>) with almost similar tensile strength. …”
  7. 1447

    Upcycling of Postconsumer Recyclate Polypropylene into Low Warping and High Toughness 3D Printable Filaments by Animesh Gopal (18521180)

    Published 2025
    “…Incorporation of poly­(butylene adipate-<i>co</i>-terephthalate) (PBAT) along with maleic anhydride grafted polypropylene (MAPP) in specific proportions led to a significant enhancement in mechanical properties, miscibility, crystallization behavior, and 3D printability. rPP/PBAT blends with 20 wt % PBAT and 10 wt % MAPP exhibited a 62-fold enhancement in elongation at break over rPP (from 1.88 to 118.29%) and a 72-fold increase in toughness (from 2 to 143.60 kJ/m<sup>3</sup>) with almost similar tensile strength. …”
  8. 1448

    Elevated PE level in yeast decreases the sensitivity of replicating tombusvirus RNA to the reconstituted RNAi. by Nikolay Kovalev (184967)

    Published 2017
    “…<p>(A-B) Induction of RNAi in <i>cho2Δ</i> yeast inhibits TBSV repRNA accumulation less effectively than in wt yeast. …”
  9. 1449

    Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia by Jingping Ge (636557)

    Published 2015
    “…We also observed the up-regulation of <i>TGFβ1R</i>, <i>TGFβ2</i>, <i>CDKN1A</i> and <i>SERPINE1</i> mRNA, and the significant decrease of <i>GATA1</i> mRNA in the primitive multilineage progenitors. …”
  10. 1450
  11. 1451

    Analysis of DRD1 and DRD2 signalling upon dopamine treatment in SH-SY5Y-DRD1 or -DRD2 stable lines untransduced or transduced by WT or G2019S LRRK2. by Mauro Rassu (4068670)

    Published 2017
    “…<p><b>(A)</b> Cells stably expressing FLAG-tagged DRD1 were transduced by the different LRRK2 isoforms. 48h after transduction the cell were treated for different time points (15', 30', 60') by dopamine. …”
  12. 1452

    CC-1<sup>+</sup> immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

    Published 2015
    “…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1<sup>+</sup> oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”
  13. 1453
  14. 1454
  15. 1455
  16. 1456
  17. 1457
  18. 1458

    <i>skn-1b</i> is not required for WT or <i>daf-2</i> longevity A-F) Survival of WT and <i>skn-1b</i> mutants in the absence and presence of <i>daf-2</i> mutation. by Nikolaos Tataridas-Pallas (10231350)

    Published 2021
    “…We conclude that <i>skn-1b</i> does not contribute to <i>daf-2</i> longevity. In a total of 15 trials (13 on OP50, 2 on HT115) bacteria we observed a slight decrease in <i>skn-1b</i> longevity compared to WT in 4 trials (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s004" target="_blank">S4</a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s005" target="_blank">S5</a> Tables). …”
  19. 1459
  20. 1460